Skip to main content

Shionogi &

Shionogi & Co Ltd is a Japanese pharmaceutical enterprise engaged in the research, development, manufacturing, and marketing of prescription medicines and diagnostic reagents. The company's primary therapeutic focus areas comprise infectious diseases, central nervous system disorders, and pain management solutions. Revenue is driven by domestic sales of prescription pharmaceuticals in Japan alongside substantial international royalty income from licensed HIV therapies like dolutegravir. Target end markets include retail pharmacies, hospital networks, government healthcare programs, and medical practitioners globally. Shionogi holds a leading position among Japanese biopharmaceutical companies, recognized particularly for its anti-infective and antiviral drug discovery pipeline. The company is headquartered in Osaka, Japan, and its common shares trade on the Tokyo Stock Exchange under the ticker symbol 4507.

48 of the funds FundTelligence covers report a position in Shionogi &.

Legal name
Shionogi & Co Ltd
Sector
Health Care
Country
Japan
Funds holding it
48

Funds holding Shionogi &

Showing the 8 largest of 48 funds holding it.

Loading...